(RTTNews) - Exact Sciences Corp. (EXAS), Friday announced the landmark clinical results from its ALTUS study, showing that the Oncoguard Liver blood test significantly outperforms ultrasound in ...
Oncoguard® Liver blood test delivers six times greater sensitivity for very early-stage hepatocellular carcinoma (HCC) versus standard of care. These findings will be presented as late-breaking data ...
Study Finds on MSN
Liver cells under chronic dietary stress show cancer warning signs years before tumors appear
Scientists identify measurable cellular changes that flag higher cancer risk more than a decade before tumors appear. In A ...
A new scoring system using common clinical parameters accurately identifies chronic liver disease patients with a significantly increased risk of developing liver cancer. This tool acts as a universal ...
ALTUS study is the largest prospective trial of a blood test for liver cancer surveillance in the United States, reflecting the racial and ethnic diversity of high-risk groups Exact Sciences Corp.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback